Skin quality has become an increasingly important part of the conversation around facial rejuvenation.

Volume restoration still matters, but the way skin looks and feels is influenced by much more than volume alone. Collagen, elastin, hydration, and fibroblast activity all contribute to the structure and appearance of the skin.

This broader view is one reason biostimulation and hybrid dermal fillers are receiving more attention in aesthetic medicine.

An in vitro study published in Aesthetic Plastic Surgery examined the formulation used in Genefill DX, combining cross-linked hyaluronic acid with dextranomer microspheres. Researchers evaluated its rheological and physicochemical properties alongside several biological markers associated with extracellular matrix activity, including different collagen types, elastin, fibroblast migration, hydration, and cytokine response.

So, what did the study actually examine, and why do these markers matter when we talk about skin quality and facial rejuvenation?

Looking Beyond Volume in Facial Rejuvenation

Dermal fillers have traditionally been associated with restoring lost volume, smoothing visible folds, and supporting facial contours.

But the science around injectable aesthetics increasingly considers a wider set of biological processes.

The extracellular matrix — the structural network surrounding cells within the skin — contains components including collagen, elastin, and hyaluronic acid. These elements contribute to skin structure, flexibility, hydration, and overall tissue quality.

The study behind Genefill DX was designed to explore this wider picture.

Rather than looking only at the filler’s ability to provide volume, researchers assessed how the HA + dextranomer formulation interacted with normal human dermal fibroblasts and other cell models in vitro. The study compared measures including collagen production, elastin, fibroblast migration, hydration, and cytokine activity.

This makes the research particularly relevant to the growing discussion around hybrid fillers and biostimulation.

Why Collagen Matters to Skin Quality

Collagen is one of the main structural proteins found within the skin and extracellular matrix.

But collagen is not a single substance.

Different collagen types perform different structural roles, which is why the study measured several of them separately: collagen I, III, IV, and VI.

Collagen I and III

Types I and III are closely associated with the structural framework of the dermis.

In the study, treatment with HA + dextranomer significantly increased collagen I production compared with the untreated control across all measured time points. Collagen III also increased significantly at 24 hours, although that effect changed over time.

These findings are important because they suggest that the HA + dextranomer formulation did more in the experimental model than simply occupy space.

It influenced fibroblast activity associated with the production of key extracellular matrix components.

Collagen IV and VI

The researchers also looked beyond the collagen types most commonly discussed in aesthetics.

Collagen IV is associated with basement membrane structures, while collagen VI contributes to the organization of the extracellular matrix.

The study reported sustained increases in collagen IV with HA + dextranomer through the measured period. Both HA and HA + dextranomer increased collagen VI, although the response was more pronounced and sustained with HA + dextranomer.

Taken together, these findings are one reason the study presents Genefill DX within a broader biostimulatory and regenerative aesthetics discussion rather than considering the formulation only as a volumising filler.

Elastin: Another Part of the Skin-Quality Picture

Collagen tends to receive most of the attention when discussing skin structure, but elastin is another important component.

As its name suggests, elastin contributes to the skin’s ability to stretch and return toward its original shape.

In the Genefill DX study, HA + dextranomer significantly increased elastin production in the fibroblast model, with the effect observed from 24 hours and maintained across the study period. The HA-only comparator did not produce a significant increase in elastin at the measured time points.

This matters because skin quality is not defined by one marker. Collagen production, elasticity, hydration, and cellular activity all contribute different pieces to the overall picture.

The study’s assessment of both collagen and elastin therefore provides a broader view of how the formulation interacted with the extracellular matrix in vitro.

Fibroblasts: The Cells Behind the Matrix

To understand why these findings matter, it helps to understand the role of fibroblasts.

Fibroblasts are cells involved in producing and maintaining components of the extracellular matrix, including collagen.

The study evaluated fibroblast behaviour using a scratch or “wound-healing” assay, a laboratory method used to measure how cells migrate across a defined gap.

At 24 hours, both the HA filler and HA + dextranomer treatment showed greater wound closure than the untreated control. By 48 hours, the HA + dextranomer group showed greater closure than HA alone, and by 72 hours the HA + dextranomer-treated cell layer had achieved complete closure in the experimental model.

It is important to understand what this result means — and what it does not.

This was an in vitro cell-migration experiment, not a clinical wound-healing study in patients.

What it does provide is evidence that HA + dextranomer influenced fibroblast migration under controlled laboratory conditions, adding another layer to the study’s investigation of tissue-remodelling activity.

Hydration: Where Hyaluronic Acid Still Plays a Central Role

Hyaluronic acid is widely known for its ability to interact with and retain water, which is one reason it plays such an important role in aesthetic formulations.

The study assessed cellular water content over 24, 48, and 72 hours.

Both the HA-only filler and HA + dextranomer increased cellular hydration compared with the control. The HA-only formulation produced a stronger early hydration effect, while the researchers reported that hydration associated with HA + dextranomer became more stable over time.

This is an interesting part of the study because it shows that hybrid filler performance cannot be reduced to a single measurement.

The formulation was not simply evaluated on whether it hydrated more than another filler at one time point.

Instead, hydration was one part of a larger set of measurements that included collagen, elastin, fibroblast behaviour, rheology, and cytokine response.

That broader perspective is particularly relevant when discussing skin quality.

Why Did the Researchers Measure Cytokines?

Cytokines are signalling molecules involved in communication between cells.

They play complex roles in inflammation, repair, immune activity, and extracellular matrix regulation.

The study measured several cytokines, including TGF-β1, IL-1β, IL-6, IL-10, and TNFα, in fibroblast and monocyte models.

The researchers reported changes in several of these markers following treatment with HA + dextranomer. These included increased TGF-β1 and IL-10 in parts of the experimental model, alongside changes in inflammatory markers such as IL-1β and TNFα.

Why is that relevant?

Because collagen production and extracellular matrix activity do not happen independently. Cellular signalling helps regulate the behaviour of fibroblasts and other cells involved in tissue maintenance and remodelling.

TGF-β1, for example, is closely associated with fibroblast activity and extracellular matrix production. The authors therefore considered the cytokine findings alongside the increases they observed in collagen and elastin.
‍

For readers, the key point is that the study looked at multiple biological pathways rather than relying on one marker to describe biostimulatory activity.

What Makes Genefill DX a Hybrid Filler?

The study examined the formulation combining cross-linked hyaluronic acid with dextranomer microspheres.

This combination is what places Genefill DX within the category of hybrid dermal fillers. The two components bring different characteristics to the formulation.

Hyaluronic acid contributes the well-established volumising and hydrating properties associated with HA fillers, while dextranomer introduces the biostimulatory element being explored in the study.

The researchers therefore examined both sides of that profile: physical behaviour such as hydration and rheology, alongside biological responses such as collagen production, elastin, fibroblast migration, and cytokine modulation.

This dual focus reflects the wider concept behind hybrid biostimulation: facial rejuvenation does not have to be discussed only in terms of adding volume.

What Does the Study Suggest About Skin Quality?

Perhaps the most useful way to interpret the research is not to focus on one isolated result. Instead, the study brings several findings together.

In the laboratory model, HA + dextranomer was associated with:

• Increased production of collagen I, III, IV, and VI
• Increased elastin production
• Enhanced fibroblast migration
• Changes in cytokines associated with extracellular matrix activity
• Maintenance of cellular hydration over time

Together, these findings support further investigation of Genefill DX as more than a conventional volume-restoration product.

They also help explain why terms such as biostimulation, skin quality, extracellular matrix, and hybrid facial rejuvenation are becoming increasingly connected.

The concept is broader than simply filling a line or adding projection. It is about understanding how structural support and biological activity may contribute to the overall aesthetic result.

Why the In Vitro Context Matters

The study produced interesting findings, but the way those findings are interpreted matters.

This was an in vitro experimental study, meaning the biological testing was performed using cell cultures under controlled laboratory conditions rather than directly in patients.

The authors themselves note that in vitro models cannot fully reproduce the complexity of living tissue and that further in vivo research is needed to validate the results.

That distinction is important.

An increase in collagen production in cultured fibroblasts does not automatically translate into an identical level of collagen production or a guaranteed visible result in a patient.

Instead, the study provides mechanistic evidence — information about how the formulation interacted with cells and extracellular matrix markers under experimental conditions.

For evidence-based aesthetic medicine, that is valuable because it helps build the scientific foundation for further clinical investigation.

From Volume to a Broader View of Facial Rejuvenation

The Genefill DX study reflects a wider change in aesthetic medicine.

Facial rejuvenation is increasingly being discussed in terms of multiple interconnected goals: restoring volume, supporting facial structure, considering skin quality, and understanding biological processes within the extracellular matrix.

Hybrid fillers sit naturally within that conversation.

By combining hyaluronic acid with a biostimulatory component, Genefill DX represents an approach designed to consider both structural correction and biological activity.

The study adds laboratory evidence to that concept by examining collagen, elastin, fibroblast migration, hydration, and cytokine activity rather than looking at volume alone.

These findings contribute to a more detailed understanding of how hybrid formulations behave, why product composition matters, and how the role of dermal fillers is being explored beyond traditional volume restoration.

What Comes Next?

The study provides a detailed experimental picture of how HA + dextranomer interacted with fibroblasts, monocytes, and extracellular matrix markers.

The next step is continued research.

Further in vivo and clinical studies can help determine how these laboratory observations translate into patient outcomes over time and how changes in collagen, elastin, hydration, and other markers relate to visible improvements in skin quality.

That distinction between promising biological evidence and demonstrated clinical outcomes is essential as regenerative and biostimulatory aesthetics continue to develop.

What this study does provide is a stronger scientific framework for understanding Genefill DX as a hybrid formulation — one that brings together the familiar properties of hyaluronic acid with a dextranomer-based biostimulatory component.

And as facial aesthetics continues to move beyond volume alone, understanding that broader biological picture is becoming increasingly relevant.

Read the full published study to explore the methodology, results, and comparative findings in greater detail.

To learn more about Genefill DX and its role within the Genefill facial portfolio, contact us.

‍